The merger gets Punjab & Haryana High Court go-ahead; deal to close after brand dilutions The $4-billion merger between Sun Pharmaceutical Industries and Ranbaxy Laboratories has crossed the final......
The Ranbaxy brand might be gradually phased out in the near future in the wake of this year’s largest merger in the Asian pharma sector. After Monday’s conditional nod from the......
The coming together of India's two very large drug makers, Sun Pharmaceutical Industries and Ranbaxy Laboratories, has created a stir in the pharmaceutical world. Sun's $3.2-billion all-share......
It's a classic David versus Goliath duel.On the one hand are the minnows; on the other, giants. But the tiny ones are beginning to challenge the big boys on their turf, making them squirm in their......
Does Volmax sound similar to Voltas? That is the question which the Intellectual Property Appellate Boardwill have to consider again as the 12-year old brand dispute between multinational drug......